Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2000;96:517-520
© 2000 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PROPST, A. M.
Right arrow Articles by GINSBURG, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PROPST, A. M.
Right arrow Articles by GINSBURG, E. S.

ORIGINAL RESEARCH

Complications of Hysteroscopic Surgery: Predicting Patients at Risk

ANTHONY M. PROPST, MD, REBECCA F. LIBERMAN, MPH, BERNARD L. HARLOW, PhD and ELIZABETH S. GINSBURG, MD

From the Department of Obstetrics, Gynecology and Reproductive Biology, the Division of Reproductive Medicine, and the Department of Obstetrics and Gynecology Epidemiology Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts.

Address reprint requests to: Anthony M. Propst, MD Brigham and Women’s Hospital Department of Obstetrics and Gynecology 75 Francis Street Boston, MA 02115 E-mail: ampropst{at}bics.bwh.harvard.edu


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Objective: To determine the frequency of operative complications and whether they can be predicted by specific patient characteristics or type of hysteroscopic procedure.

Methods: We collected demographic and medical history information on 925 women who had hysteroscopies from 1995 through 1996. We compared differences in rates of operative complications of specific hysteroscopic procedures. Operative complications were defined as uterine perforation, excessive glycine absorption (1 L or more), hyponatremia, hemorrhage (500 mL or more), bowel or bladder injury, inability to dilate the cervix, and procedure-related hospital admissions.

Results: Operative complications occurred in 25 (2.7%) of 925 hysteroscopies. Excessive fluid absorption was the most frequent complication. Hysteroscopic myomectomy and resection of uterine septum were associated with greater odds of complications (odds ratio [OR] 7.4, 95% confidence interval [CI] 3.3, 16.6 and OR 4.0, 95% CI 0.9, 19.6, respectively). Hysteroscopic polypectomy and endometrial ablation were associated with lower odds of complications (OR 0.1, 95% CI 0.0, 0.7 and OR 0.4, 95% CI 0.1, 3.3, respectively). Hysteroscopies done by reproductive endocrinologists and preoperative GnRH agonist therapy were associated with 4–7 times higher odds for operative complications.

Conclusion: Complications during hysteroscopic surgery are rare. Among hysteroscopic procedures, myomectomies and resections of uterine septa have significantly higher rates of complications, especially excessive fluid absorption. Meticulous fluid management might limit the number of serious complications of these higher-risk procedures.

During the past decade, the number of gynecologists doing operative hysteroscopy and the number of procedures done have increased.1 The incidence of complications from hysteroscopy varies widely by institution and operative procedure.1–3 Appropriateness and safety of hysteroscopy depend on predicting complications. Our objectives were to determine frequency and to identify predictors of complications of different hysteroscopic operations.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
We reviewed medical records of 925 women who had hysteroscopies by general obstetrician-gynecologists, reproductive endocrinologists, and gynecologic oncologists at Brigham and Women’s Hospital between January 1, 1995, and December 31, 1996. During the study, seven reproductive endocrinologists, four gynecologic oncologists, and more than 30 general obstetrician-gynecologists performed 1034 hysteroscopic surgeries. Ninety percent of subject records were available for review. The institutional review board approved our study.

Information abstracted from medical records included age, gravidity, parity, height, weight, uterine surgery, medications, menopausal status, index hysteroscopy (diagnostic procedure, polypectomy, myomectomy, endometrial ablation, uterine septum resection, lysis of adhesions, endometrial curettage), concomitant procedures (laparoscopy, laparotomy), preoperative and postoperative diagnoses, surgeon, anesthesia, operative time, estimated blood loss, type and amount of distention media, media deficit, and preoperative and postoperative hematocrit and sodium levels. Surgical complications were defined as uterine perforation, excessive glycine absorption (1 L or more), hyponatremia (less than 130 mEq/L), hemorrhage (estimated blood loss of 500 mL or more), blood transfusion, unplanned hospital admission directly related to hysteroscopy, bowel or bladder injury, inability to dilate the cervix, or inability to complete the surgery because of poor visibility or excessive fluid absorption. The amount of leiomyoma tissue removed was calculated from aggregate measurements of resected tissue from the pathologist’s report.

We compared differences in complication rates by type of procedure and used stratified analyses and {chi}2 tests to estimate statistical significance. Estimates of the relative risks (RR) of operative complications by patient characteristics and medical histories were determined by logistic regression analyses and are presented as odds ratios (ORs) with 95% confidence intervals (CIs). All analyses were done using the SAS system (SAS Institute, Cary, NC).


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The mean (± standard deviation [SD]) age of the subjects was 46.5 ± 10.8 years, and the mean body mass index (BMI) was 26.0 ± 6.3 kg/m2. Thirty-four percent were nulliparous, 39.1% had one or two live births, and 27.7% had more than two live births. Operative complications occurred in 25 (2.7%) of 925 procedures, and five women had more than one complication. The complications are listed in Table 1Go. Seven women had excessive absorption, and of those, hyponatremia developed in three women. There were five cases in which the procedure was stopped before completion because the glycine deficit approached 1 L. More than 98% of the procedures used hypotonic 1.5% glycine as the uterine distention medium. Excessive glycine absorption occurred only in more complex procedures, including myomectomy, uterine septum resection, and endometrial ablation. There were four (0.4%) uterine perforations without additional damage, two caused by the operative hysteroscope, one by a metal curette, and the other by Hegar dilators during cervical dilation. No woman needed laparoscopy or laparotomy because of a complication. Four (0.4%) women were admitted overnight, two for observation after excessive fluid absorption, one for intravenous antibiotics to treat postoperative endomyometritis, and one because of persistent nausea after general anesthesia. Both women treated for postoperative endomyometritis had hysteroscopic myomectomies. No women hemorrhaged, needed blood transfusions, had bowel or bladder damage, or developed serious sequelae from hyponatremia such as pulmonary edema or encephalopathy.


View this table:
[in this window]
[in a new window]
 
Table 1. Specific Complications by Hysteroscopic Procedure*
 
Table 2Go shows the estimated risks of operative complications by demographic characteristics and medical history. Women over 50 years old had a statistically significantly reduced likelihood of complication compared with women less than 35 years old. Forty-two women received treatment with a GnRH agonist before myomectomy (n = 23), ablation (n = 11), polypectomy (n = 4), or hysteroscopy with curettage (n = 4). Women pretreated with GnRH agonists had seven times the risk of operative complications compared with untreated women. Six of 42 women pretreated with GnRH agonists had complications; four had excessive glycine absorption, one had uterine perforation, and one had endomyometritis. Hysteroscopies done by general gynecologists had lower rates of operative complications than those done by other surgeons, and those done by reproductive endocrinologists had a threefold higher risk of complications compared with those done by all other surgeons (OR 0.4 and 2.9, respectively). Preoperative GnRH agonist therapy and surgery done by reproductive endocrinologists were highly statistically significant for increased odds of operative complications in the multivariate model, which included age, preoperative GnRH agonist therapy, and type of surgeon. Weight, parity, cervical stenosis, history of cesarean delivery, and myomectomy were not associated with statistically significantly increased odds of operative complications.


View this table:
[in this window]
[in a new window]
 
Table 2. Odds of Operative Complications by Selected Patient Characteristics
 
Operative time, glycine deficit, and estimated risk of operative complications for the six most common hysteroscopic procedures are shown in Table 3Go. Surgeons’ operating times were used for those analyses. The operative times for 37 women with concomitant laparoscopy or laparotomy were excluded. Operative time, amount of glycine used, and glycine deficit were highest for myomectomies. Risk of complications increased by complexity of the procedure. Hysteroscopic myomectomy and resection of uterine septum had the highest risks of operative complications (OR 7.4 and 4.0, respectively), and diagnostic hysteroscopy with or without D&C and polypectomy had low risks of complications (OR 0.5 and 0.1, respectively). Reproductive endocrinologists did a statistically significantly larger percentage of complex hysteroscopic procedures (myomectomy, endometrial ablation, uterine septum resection, and lysis of adhesions) per total cases than general gynecologists (51% versus 19%, P = .001, {chi}2). Reproductive endocrinologists removed more leiomyoma tissue per myomectomy than general gynecologists, although the difference was not statistically significant (22,441 mm3 versus 8541 mm3, P = .11, Mann-Whitney U test).


View this table:
[in this window]
[in a new window]
 
Table 3. Operative Time, Glycine Use, and Complications
 

    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Minimally invasive procedures have many benefits compared with traditional procedures, including lower costs, shorter hospital stays, and shorter recovery time. Hysteroscopic procedures, particularly myomectomy and endometrial ablation, are effective alternatives to hysterectomies. The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas ranges from 60 to 90%.4,5 During a 16-year follow-up after hysteroscopic myomectomy, only 16% of patients needed surgery for recurrence of abnormal uterine bleeding.4

There is little information published on predictors of complications for hysteroscopic surgery despite its increasing use. Smith and colleagues2 reported a 25% complication rate in 100 women who had advanced hysteroscopic procedures, such as ablation, myomectomy, lysis of synechiae, and resection of uterine septa. Complications included uterine perforation (8%), technical problems (8%), fluid imbalance (5%), and postoperative sepsis (4%). A Scottish survey of operative hysteroscopies for menorrhagia between 1991 and 1993 reported a 12% complication rate, including fluid imbalances greater than 1 L in 6% of women, uterine perforation in 1%, excessive bleeding in 4%, and emergent laparoscopy or hysterectomy for uterine perforation in 1%.3 The 1991 American Association of Gynecologic Laparoscopists member survey reported 17,298 operative hysteroscopies with a complication rate of 3.8%, including perforation in 1%, hospital admission in 0.7%, hemorrhage in 0.2%, and unplanned laparotomy in 0.2% of women.1 Our complication rates were similar to those findings, although we had no cases of hemorrhage, transfusion, or unplanned laparotomy.

In our study, type of procedure was the strongest predictor of complications. Excessive glycine imbalance (at least 1 L) was the most common complication. Most fluid imbalances were identified quickly and treated. Among women with excessive glycine absorption, the lowest serum sodium recorded was 126 mEq/L.

We use an automatic hysteroscopic monitoring system with inflow and outflow monitors to measure fluid imbalances (Flo-Stat, FemRx, Sunnyvale, CA). Our protocol for hysteroscopic surgery is to stop the procedure when the glycine deficit is 1 L or greater. Serum sodium levels decrease about 10 mEq/L for every 1 L of hypotonic fluid absorbed.6 A large volume of uterine distention medium can be absorbed quickly with a uterine perforation or during a fibroid resection. The pressure in large venous sinuses in leiomyomas or the myometrium is 8 to 10 mmHg. Rapid intravasation can occur because the intrauterine pressure necessary for distention and flow is 40 to 60 mmHg.6

Hysteroscopies done by reproductive endocrinologists were 3.5 times more likely to have complications than those done by other gynecologic surgeons. We believe this difference is because of the type of procedure not the type of surgeon. Reproductive endocrinologists did more complex hysteroscopic myomectomies per total cases than general gynecologists, and they removed more leiomyoma tissue.

Women pretreated with GnRH agonists had greater risk of operative complications than those not pretreated. However, this higher risk was probably more a function of complication rates from specific hysteroscopic procedures rather than pretreatment with a GnRH agonist. Compared with women not pretreated, those pretreated had a significantly higher percentage of complex hysteroscopic procedures (24% versus 81%, P = .001, {chi}2); 55% had myomectomies and 26% had endometrial ablations. Pretreatment with GnRH agonists did not reduce glycine deficits. For myomectomies, women pretreated with GnRH agonists had higher glycine deficits than those not pretreated (430 mL versus 290 mL, P = .12). Other investigators reported that pretreatment with GnRH agonists reduced uterine blood flow and intraoperative uterine fluid absorption.6,7

Obesity, cervical stenosis, and history of cesarean or myomectomy did not increase the risk of operative complications. Only one woman with cervical stenosis had a uterine perforation, which suggests that in certain patients, dilation of cervical stenosis can be done safely in the operating room.

A limitation of this study was that not all of the medical records had complete information. Specifically, gravidity and parity were not recorded in 30%, and the total glycine and glycine deficit were not recorded in 47% and 20% of the records, respectively.


    Footnotes
 
Diane Bernstein and Natalie Sinclair assisted in data collection.

The opinions and conclusions in this paper are those of the authors and are not intended to represent the official position of the Department of Defense, United States Air Force or any other government agency.

PII S0029-7844(00)00958-3

Received January 13, 2000. Received in revised form April 19, 2000. Accepted May 11, 2000.


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
1. Hulka JF, Peterson HB, Phillips JM, Surrey MW. Operative hysteroscopy. American Association of Gynecologic Laparoscopists 1991 membership survey. J Reprod Med 1993;38:572–3.[Medline]

2. Smith DC, Donohue LR, Waszak SJ. A hospital review of advanced gynecologic endoscopic procedures. Am J Obstet Gynecol 1994;170: 1635–42.[Medline]

3. Scottish Hysteroscopy Audit Group. A Scottish audit of hysteroscopic surgery for menorrhagia: Complications and follow up. Br J Obstet Gynaecol 1995;102:249–54.[Medline]

4. Derman SG, Rehnstrom J, Neuwirth RS. The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas. Obstet Gynecol 1991;77:591–4.[Abstract/Free Full Text]

5. Hallez JP. Single-stage total hysteroscopic myomectomies: Indications, techniques, and results. Fertil Steril 1995;63:703–8.[Medline]

6. Issacson KB. Complications of hysteroscopy. Obstet Gynecol Clin North Am 1999;26:39–51.[Medline]

7. Parazzini F, Vercellini P, De Giorgi O, Pesole A, Ricci E, Crosignani PG. Efficacy of preoperative medical treatment in facilitating hysteroscopic endometrial resection, myomectomy and metroplasty: Literature review. Hum Reprod 1998;13:2592–7.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
A. Di Spiezio Sardo, I. Mazzon, S. Bramante, S. Bettocchi, G. Bifulco, M. Guida, and C. Nappi
Hysteroscopic myomectomy: a comprehensive review of surgical techniques
Hum. Reprod. Update, March 1, 2008; 14(2): 101 - 119.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
B. Woelfer, R. Salim, S. Banerjee, J. Elson, L. Regan, and D. Jurkovic
Reproductive Outcomes in Women With Congenital Uterine Anomalies Detected by Three-Dimensional Ultrasound Screening
Obstet. Gynecol., December 1, 2001; 98(6): 1099 - 1103.
[Abstract] [Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Hysteroscopic Surgery Carries Low Operative Risk
Journal Watch Women's Health, December 4, 2000; 2000(1204): 8 - 8.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PROPST, A. M.
Right arrow Articles by GINSBURG, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PROPST, A. M.
Right arrow Articles by GINSBURG, E. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS